Abbott acquisition of Solvay Pharmceuticals- Sep 2009

1,586
-1

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,586
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
30
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Abbott acquisition of Solvay Pharmceuticals- Sep 2009

  1. 1. Abbott’s Acquisition of Solvay Pharmaceuticals GDS_70000_Title_v1 1
  2. 2. Acquisition of Solvay Pharmaceuticals for €4.5 Billion Supports Abbott’s Long-Term Growth Strategy Abbott Strategy Solvay Brings Diversify sources of • Adds >$3B in annual long-term product revenue pharmaceuticals growth • 75% OUS revenue; 70% branded generics • Complementary product portfolio in cardiology, neuroscience and gastroenterology • Adds a growing global vaccines business and modest molecular diagnostics business Expand presence in high- • Solvay infrastructure is platform for expansion growth emerging markets • Significant presence in emerging markets, including Eastern Europe and Asia • Strong brand recognition Accelerate R&D spending to • >$500MM in incremental R&D investment capacity, adding a mix of late- and early-stage assets support long-term growth • Provides Abbott opportunity to accelerate near- and long-term pharmaceutical growth Accelerate ongoing EPS • ~$0.10 accretive to ongoing EPS in 2010 growth over the long-term • Ramping up to more than $0.20 accretion by 2012 • Ongoing EPS accretion increases after 2012 2 GDS_70000_Title_v1 2
  3. 3. Solvay Pharmaceuticals Overview Division of Solvay Group, engaged in the Overview research, manufacturing and marketing of pharmaceuticals and vaccines Headquarters Brussels, Belgium Founded 1980 Presence Active in >50 countries; products in >150 countries Major Market Cardiovascular, Neuroscience, Gastroenterology, Segments Men’s/Women’s Health and Pancreatic Enzymes 2007 Sales Product Sales Adds >$3 Billion to Abbott 3 GDS_70000_Title_v1 3
  4. 4. Solvay Pharmaceuticals Overview Geographic and Therapeutic Diversity Product Sales Product Sales by by Geography Therapeutic Area Cardiovascular United States Rest of World Men's/Women's Health Neuroscience Other Gastroenterology Pancreatic Enzymes Emerging Markets Vaccines Product Sales: Adds >$3 Billion to Abbott 4 GDS_70000_Title_v1 4
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×